Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
PR Newswire Asia
SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,..